Bilaketaren emaitzak - Haner Di̇reskeneli̇

Findu emaitzak
  1. 1
    Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51

    Behcet's disease: infectious aetiology, new autoantigens, and HLA-B51 nork Haner Direşkeneli

    Argitaratua 2001
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?

    Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? nork Haner Direşkeneli

    Argitaratua 2006
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Advances in the Treatment of Behcet’s Disease

    Advances in the Treatment of Behcet’s Disease nork Fatma Alibaz‐Öner, Haner Direşkeneli

    Argitaratua 2021
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Update on the Diagnosis of Behçet’s Disease

    Update on the Diagnosis of Behçet’s Disease nork Fatma Alibaz‐Öner, Haner Di̇reskeneli̇

    Argitaratua 2022
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Management of Takayasu arteritis: a systematic review

    Management of Takayasu arteritis: a systematic review nork Gökhan Keser, Haner Di̇reskeneli̇, Kenan Aksu

    Argitaratua 2013
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Takayasu arteritis: an update

    Takayasu arteritis: an update nork Gökhan Keser, Kenan Aksu, Haner Di̇reskeneli̇

    Argitaratua 2018
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behcet's disease.

    Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behcet's disease. nork Şükran Şahín, T Akoğlu, Haner Direşkeneli, S. Şen, Roger Lawrence

    Argitaratua 1996
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Recent advances in Takayasu's arteritis

    Recent advances in Takayasu's arteritis nork Fatma Alibaz‐Öner, Sibel Z. Aydin, Haner Direşkeneli

    Argitaratua 2015
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders

    How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders nork K. Abacar, Tom Macleod, Haner Di̇reskeneli̇, Dennis McGonagle

    Argitaratua 2024
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    The Role of Depression, Anxiety, Fatigue, and Fibromyalgia on the Evaluation of the Remission Status in Patients with Rheumatoid Arthritis

    The Role of Depression, Anxiety, Fatigue, and Fibromyalgia on the Evaluation of the Remission Status in Patients with Rheumatoid Arthritis nork Nevsun İnanç, S. Yılmaz-Öner, Meryem Can, Tuulikki Sokka, Haner Direşkeneli

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors

    Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors nork Irene Mattioli, Alessandra Bettiol, Güher Saruhan‐Direskeneli, Haner Direşkeneli, Giacomo Emmi

    Argitaratua 2021
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome

    Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome nork Vedat Hamuryudan, İzzet Fresko, Haner Di̇reskeneli̇, M. J. Tenant, Sebahattin Yurdakul, T Akoğlu, Hülya Yazıcı

    Argitaratua 1999
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study

    Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study nork Yiping Fei, Ryan Webb, Beth L. Cobb, Haner Di̇reskeneli̇, Güher Saruhan‐Direskeneli, Amr H. Sawalha

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Epigenome‐Wide Scan Identifies a Treatment‐Responsive Pattern of Altered DNA Methylation Among Cytoskeletal Remodeling Genes in Monocytes and CD4+ T Cells From Patients With Behçet's Disease

    Epigenome‐Wide Scan Identifies a Treatment‐Responsive Pattern of Altered DNA Methylation Among Cytoskeletal Remodeling Genes in Monocytes and CD4+ T Cells From Patients With Behçet... nork Travis K. Hughes, Filiz Türe Özdemir, Fatma Alibaz‐Öner, Patrick Coit, Haner Di̇reskeneli̇, Amr H. Sawalha

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review

    Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review nork Gülen Hatemi, Peter A. Merkel, Vedat Hamuryudan, Maarten Boers, Haner Di̇reskeneli̇, Sibel Z. Aydin, Hasan Yazıcı

    Argitaratua 2014
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Monitoring Achilles enthesitis in ankylosing spondylitis during TNF- antagonist therapy: an ultrasound study

    Monitoring Achilles enthesitis in ankylosing spondylitis during TNF- antagonist therapy: an ultrasound study nork Sibel Zehra Aydın, Ömer Karadağ, E. Filippucci, Pamir Atagündüz, Ali Akdoğan, U. Kalyoncu, Walter Grassi, Haner Di̇reskeneli̇

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    The close association between dental and periodontal treatments and oral ulcer course in behcet’s disease: a prospective clinical study

    The close association between dental and periodontal treatments and oral ulcer course in behcet’s disease: a prospective clinical study nork Ümit Karaçaylı, Gonca Mumcu, İsmail Şimşek, Salih Pay, Ösman Kose, Hakan Erdem, Haner Di̇reskeneli̇, Yılmaz Günaydin, Ayhan Dinç

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis

    The OMERACT Core Set of Outcome Measures for Use in Clinical Trials of ANCA-associated Vasculitis nork Peter A. Merkel, Sibel Zehra Aydın, Maarten Boers, Haner Di̇reskeneli̇, Karen Herlyn, Philip Seo, Ravi Suppiah, Gunnar Tómasson, Raashid Luqmani

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Development of Outcome Measures for Large-vessel Vasculitis for Use in Clinical Trials: Opportunities, Challenges, and Research Agenda

    Development of Outcome Measures for Large-vessel Vasculitis for Use in Clinical Trials: Opportunities, Challenges, and Research Agenda nork Haner Di̇reskeneli̇, Sibel Z. Aydin, Tanaz A. Kermani, Eric L. Matteson, Maarten Boers, Karen Herlyn, Raashid Luqmani, Tuhina Neogi, Philip Seo, Ravi Suppiah, Gunnar Tómasson, Peter A. Merkel

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Activation of the JAK/STAT pathway in Behcet’s disease

    Activation of the JAK/STAT pathway in Behcet’s disease nork Aysın Tulunay Virlan, Mikhail G. Dozmorov, Filiz Türe Özdemir, Sezai Yılmaz, Emel Ekşioğlu, Fatma Alibaz‐Öner, G. Özen, Jonathan D. Wren, Güher Saruhan‐Direskeneli, Amr H. Sawalha, Haner Di̇reskeneli̇

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: